West Pharmaceutical Servs (WST) closed at $406.99 on November 3, 2026, down 0.2% from the previous close, on volume of 997,817 shares (30-day average 626,197).
Data as of November 3, 2026.
West Pharmaceutical Services Raises Outlook After Strong Earnings Call
TipRanks (Mon, 2-Nov 7:20 PM ET)
TD Cowen Sticks to Their Buy Rating for West Pharmaceutical Services (WST)
TipRanks (Fri, 30-Oct 9:07 AM ET)
Barclays Keeps Their Buy Rating on West Pharmaceutical Services (WST)
TipRanks (Fri, 30-Oct 5:47 AM ET)
Ten healthcare stocks with the highest RSI readings as earnings season heats up
Seeking Alpha News (Thu, 29-Oct 10:24 AM ET)
West Pharmaceutical Services Raises Outlook After Strong Q3
TipRanks (Thu, 29-Oct 7:29 AM ET)
West Pharmaceutical beats top-line and bottom-line estimates; raises FY26 outlook
Seeking Alpha News (Thu, 29-Oct 6:09 AM ET)
West Reports Third-Quarter 2026 Results
PRNewswire (Thu, 29-Oct 6:01 AM ET)
West Declares Quarterly Dividend
PRNewswire (Mon, 19-Oct 6:04 PM ET)
West to Host Third-Quarter 2026 Conference Call
PRNewswire (Thu, 8-Oct 6:02 AM ET)
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
PRNewswire (Mon, 5-Oct 6:00 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of November 3, 2026, WST stock price declined to $406.99 with 997,817 million shares trading.
WST has a beta of 0.48, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.03 to the broad based SPY ETF.
WST has a market cap of $28.35 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $874 million in Revenue and $2.66 earnings per share. This beat revenue expectation by $48 million and exceeded earnings estimates by $.47.
In the last 3 years, WST traded as high as $438.27 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, IVV, VUG.
WST has outperformed the market in the last year with a price return of +44.6% while the SPY ETF gained +11.7%. WST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.4% and +6.0%, respectively, while the SPY returned +1.2% and -1.6%, respectively.
WST support price is $401.93 and resistance is $413.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.
